Close Menu

NEW YORK – Illumina and Genomic Medicine Sweden (GMS) on Thursday announced a collaboration to assess whether whole-genome sequencing (WGS) and RNA sequencing can replace conventional first-line clinical diagnostic methods for acute leukemia.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.